In a 2025 survey, the rising cost of clinical trials was the leading challenge for drug developers at ** percent. Patient recruitment for clinical trials was ranked as the second leading challenge in drug development.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Thermo Fisher (PPD). (February 17, 2026). Leading clinical challenges in drug development as of August 2025 [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 22, 2026, from /statistics/1662091/major-clinical-challenges-for-drug-developers/
Thermo Fisher (PPD). "Leading clinical challenges in drug development as of August 2025." Chart. February 17, 2026. ÌÇÐÄÆÆ½â°æ. Accessed July 22, 2026. /statistics/1662091/major-clinical-challenges-for-drug-developers/
Thermo Fisher (PPD). (2026). Leading clinical challenges in drug development as of August 2025. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 22, 2026. /statistics/1662091/major-clinical-challenges-for-drug-developers/
Thermo Fisher (PPD). "Leading Clinical Challenges in Drug Development as of August 2025." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 17 Feb 2026, /statistics/1662091/major-clinical-challenges-for-drug-developers/
Thermo Fisher (PPD), Leading clinical challenges in drug development as of August 2025 ÌÇÐÄÆÆ½â°æ, /statistics/1662091/major-clinical-challenges-for-drug-developers/ (last visited July 22, 2026)
Leading clinical challenges in drug development as of August 2025 [Graph], Thermo Fisher (PPD), February 17, 2026. [Online]. Available: /statistics/1662091/major-clinical-challenges-for-drug-developers/